| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.033 | 0.4 |